192941-35-8

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 3-[2-[(methylsulfonyl)oxy]ethyl]-3-phenyl-, 1,1-dimethylethyl ester
• CAS NO: 192941-35-8
• Molecular Formula: C18H27NO5S
• Molecular Weight: 369.482
• Mol File: 192941-35-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 3-[2-[(methylsulfonyl)oxy]ethyl]-3-phenyl-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 3-[2-[(methylsulfonyl)oxy]ethyl]-3-phenyl-, 1,1-dimethylethyl ester(192941-35-8)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 3-[2-[(methylsulfonyl)oxy]ethyl]-3-phenyl-, 1,1-dimethylethyl ester(192941-35-8)

Safety Data

• Hazardous Substances Data: 192941-35-8(Hazardous Substances Data)

Upstream product

• 192940-81-1 1-(t-butoxycarbonyl)-3-phenyl-3-(2-hydroxyethyl)pyrrolidine 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 192940-82-2 1-t-butoxycarbonyl-3-(2-(4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)ethyl)-3-phenylpyrrolidine 

Relevant articles and documents

Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases

The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.